Adial Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| STONEPINE CAPITAL MANAGEMENT, LLC | 08/14/2026 | 727.56 K | $1.58 M | 100.00% | 15.74% |
| JANE STREET GROUP, LLC | 08/14/2026 | 32.12 K | $82.23 K | 100.00% | 0.70% |
| CITADEL ADVISORS LLC | 09/02/2026 | 29.55 K | $75.64 K | 100.00% | 0.64% |
| STONEX GROUP INC. | 08/12/2026 | 19.70 K | $35.67 K | 100.00% | 0.43% |
| UBS GROUP AG | 08/13/2026 | 19.15 K | $49.02 K | 3,432.66% | 0.41% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 12.39 K | $31.73 K | -48.89% | 0.27% |
| CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 07/24/2026 | 8.00 K | $20.48 K | 100.00% | 0.17% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 5.88 K | $15.05 K | 0.00% | 0.13% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 5.83 K | $14.93 K | 1,515.24% | 0.13% |
| MANCHESTER CAPITAL MANAGEMENT LLC | 08/13/2026 | 1.92 K | $4.92 K | 0.00% | 0.04% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/11/2026 | 1.42 K | $3.63 K | 4.65% | 0.03% |
| BLACKROCK, INC. | 08/07/2026 | 304 | $778 | -72.61% | 0.01% |
| RAFFA WEALTH MANAGEMENT, LLC | 07/27/2026 | 83 | $212 | 0.00% | 0.00% |
| MORGAN STANLEY | 08/13/2026 | 50 | $128 | 0.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 07/23/2026 | 47 | $120 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 08/14/2026 | 6 | $15 | 0.00% | 0.00% |
| HARBOUR INVESTMENTS, INC. | 08/12/2026 | 3 | $8 | 0.00% | 0.00% |
| ABOUND WEALTH MANAGEMENT | 07/10/2026 | 1 | $3 | 0.00% | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 08/12/2026 | 0 | $0 | -100.00% | 0.00% |
| CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 08/05/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Adial Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 24 institutional investors and hedge funds held shares of Adial Pharmaceuticals Inc. The most heavily invested institutionals were:
Stonepine Capital Management, LLC: 727,563
JANE STREET GROUP, LLC: 32,119
CITADEL ADVISORS LLC: 29,547
StoneX Group Inc.: 19,699
UBS Group AG: 19,147
GEODE CAPITAL MANAGEMENT, LLC: 12,393
18.69% of Adial Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 1.06 M shares in the last 24 months. This purchase volume represents approximately $1.83 M in transactions.